The use of neuromodulators has increased by approximately 748 percent from 2000 to 2014 and has become an integral adjunct for facial rejuvenation. Knowledge of facial anatomy, accurate facial analysis, and familiarity with neurotoxin characteristics will minimize complications and optimize results. Current approved neurotoxins in Italy include onabotulinumtoxin A (Vistabex), abobotulinumtoxin A (Azzalure), and incobotulinumtoxin A (Bocouture).
The dosage and effect of these products are not interchangeable, so practitioners should master the utility and response of one product before trying the other products. All products have equivalent success in appropriately trained hands. This course provides a stepwise approach to treat dynamic facial rhytides with neuromodulators, including indications, facial analysis, preparation and injection technique, post-procedure care, and complications.
|Saturday 20 July 2019|
|Start on||20 July 2019|
|Address||Work in progress|
|Program||Work in progress|